The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
The Role of Chemotherapy at the End of Life: “When Is Enough, Enough?”
Open accessAbstract
Patients face difficult decisions about chemotherapy near the end of life. Such treatment might prolong survival or reduce symptoms but cause adverse effects, prevent the patient from engaging in meaningful life review and preparing for death, and preclude entry into hospice. Palliative care and oncology clinicians should be logical partners in caring for patients with serious cancers for which symptom control, medically appropriate goal setting, and communication are paramount, but some studies have shown limited cooperation. We illustrate how clinicians involved in palliative care and oncology can more effectively work together with the story of Mr L, a previously healthy 56-year-old man, who wanted to survive his lung cancer at all costs. He lived 14 months with 3 types of chemotherapy, received chemotherapy just 6 days before his death, and resisted entering hospice until his prognosis and options were explicitly communicated. Approaches to communication about prognosis and treatment options and questions that patients may want to ask are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1951) · Cited by 8,693
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
Tannock, I. F., de Wit, R., Berry, W. R., Horti, J., Pluzanska, A., Chi, K. N., Oudard, S., Théodore, C., James, N. D., Turesson, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040720 · Cited by 5,735
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
Shepherd, F. A., Rodrigues Pereira, J., Ciuleanu, T., Tan, E. H., Hirsh, V., Thongprasert, S., Campos, D., Maoleekoonpiroj, S., Smylie, M., Martins, R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050753 · Cited by 5,419
Caregiving as a Risk Factor for Mortality: The Caregiver Health Effects Study
Schulz, R., & Beach, S. R. (1999) · JAMA · doi:10.1001/jama.282.23.2215 · Cited by 3,340 · cited 1×
“Oncologists consistently overestimated prognosis by at least 30%.(17) In our own study, physicians’ estimate of survival could be divided by 3.”
BackgroundFour Models of the Physician-Patient Relationship
Emanuel, E. J. (1992) · JAMA · doi:10.1001/jama.1992.03480160079038 · Cited by 2,453
Shepherd, F. A., Dancey, J. E., Ramlau, R., Mattson, K. V., Gralla, R. J., O’Rourke, M. A., Levitan, N. I., Gressot, L., Vincent, M. D., Burkes, R. L., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.10.2095 · Cited by 2,178
THE NATURE OF SUFFERING AND THE GOALS OF MEDICINE
Cassel, E. J. (1982) · New England Journal of Medicine · doi:10.1056/nejm198203183061104 · Cited by 2,149
Smith, T. J., Khatcheressian, J. L., Lyman, G. H., Ozer, H., Armitage, J. O., Balducci, L., Bennett, C. L., Cantor, S. B., Crawford, J., Cross, S. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.4451 · Cited by 1,634
Self-citationPfister, D. G., Johnson, D. H., Azzoli, C. G., Sause, W. T., Smith, T. J., Baker, S., Olak, J., Stover, D. E., Strawn, J. R., Turrisi, A. T., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.053 · Cited by 1,411
Self-citationA systematic review of physicians' survival predictions in terminally ill cancer patients
Glare, P. A., Virik, K., Jones, M., Hudson, M., Eychmuller, S., Simes, J., & Christakis, N. (2003) · BMJ · doi:10.1136/bmj.327.7408.195 · Cited by 1,025
Research works printed but not linked: 3
- [41]Hayes DF. An overview of treatment for locally advanced recurrent, and metastatic breast cancer. In: Rose BF, editor. UptoDate. Waltham, MA: UpToDate; 2008. [Google Scholar]
- [78]Emanuel LL, Ferris FD, von Gunten CF, Von Roenn J. Education in Palliative and End of Life Care for Oncology [CD-ROM] Chicago, IL: EPEC-O; 2007. NIH publication 07–6114. [Google Scholar]
- [80]Finn J, Pienta K, Parzuchowski J. Palliative care project: bridging cancer treatment and hospice care. Proc Am Soc Clin Oncol. 2002;21:1452. [Google Scholar]
Cited by
Sorted by citations
Wright, A. A. (2008) · JAMA · doi:10.1001/jama.300.14.1665 · Cited by 2,788
Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis
Levit, L. A., Balogh, E. P., Nass, S. J., & Ganz, P. A. (2014) · Cited by 956
Azzoli, C. G., Baker, S., Temin, S., Pao, W., Aliff, T., Brahmer, J., Johnson, D. H., Laskin, J. L., Masters, G., Milton, D., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.5622 · Cited by 915
Self-citationBending the Cost Curve in Cancer Care
Smith, T. J., & Hillner, B. E. (2011) · New England Journal of Medicine · doi:10.1056/nejmsb1013826 · Cited by 397
Self-citationPhysician factors associated with discussions about end‐of‐life care
Keating, N. L., Landrum, M. B., Rogers, S. O., Baum, S. K., Virnig, B. A., Huskamp, H. A., Earle, C. C., & Kahn, K. L. (2010) · Cancer · doi:10.1002/cncr.24761 · Cited by 345
Wright, A. A., Zhang, B., Keating, N. L., Weeks, J. C., & Prigerson, H. G. (2014) · BMJ · doi:10.1136/bmj.g1219 · Cited by 340
Everyday ethics: ethical issues and stress in nursing practice
Ulrich, C. M., Taylor, C., Soeken, K., O’Donnell, P., Farrar, A., Danis, M., & Grady, C. (2010) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2010.05425.x · Cited by 305
“Harrington and Smith (2008) note that “even clinicians who are well trained and skilled at giving bad news can find it burdensome and emotionally J Adv Nurs.”
BackgroundMack, J. W., & Smith, T. J. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.4564 · Cited by 299
Self-citationObermeyer, Z., Makar, M., Abujaber, S., Dominici, F., Block, S. D., & Cutler, D. (2014) · JAMA · doi:10.1001/jama.2014.14950 · Cited by 281
Health Care Costs for Patients With Cancer at the End of Life
Chastek, B. J., Harley, C., Kallich, J. D., Newcomer, L. N., Paoli, C. J., & Teitelbaum, A. H. (2012) · Journal of Oncology Practice · doi:10.1200/jop.2011.000469 · Cited by 259
Morden, N. E., Chang, C., Jacobson, J. O., Berke, E. M., Bynum, J., Murray, K. M., & Goodman, D. C. (2012) · Health Affairs · doi:10.1377/hlthaff.2011.0650 · Cited by 216
Impact of aggressive management and palliative care on cancer costs in the final month of life
Cheung, M. C., Earle, C. C., Rangrej, J., Ho, T. H., Liu, N., Barbera, L. C., Saskin, R., Porter, J., Seung, S. J., & Mittmann, N. (2015) · Cancer · doi:10.1002/cncr.29485 · Cited by 179
Dow, L. A., Matsuyama, R. K., Ramakrishnan, V., Kuhn, L., Lamont, E. B., Lyckholm, L., & Smith, T. J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.6397 · Cited by 180
Self-citationPalliative chemotherapy during the last month of life
Näppä, U., Lindqvist, O., Rasmussen, B. H., & Axelsson, B. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq778 · Cited by 158
Apolone, G., Corli, O., Caraceni, A. T., Negri, E., Deandrea, S., Montanari, M., & Greco, T. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605053 · Cited by 154
(2010) · PubMed · Cited by 151
Self-citationBELCARO, G. V., Hosoi, M., PELLEGRINI, L., Appendino, G., IPPOLITO, E., Ricci, A., Ledda, A. G., Dugall, M., Cesarone, M. R., Maione, C., et al. (2013) · Phytotherapy Research · doi:10.1002/ptr.5014 · Cited by 136
Use of chemotherapy near the end of life: what factors matter?
Rochigneux, P., Raoul, J., Beaussant, Y., Aubry, R., Goldwasser, F., Tournigand, C., & Morin, L. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw654 · Cited by 135
Discussions With Physicians About Hospice Among Patients With Metastatic Lung Cancer
Huskamp, H. A., Keating, N. L., Malin, J. L., Zaslavsky, A. M., Weeks, J. C., Earle, C. C., Teno, J. M., Virnig, B. A., Kahn, K. L., He, Y., et al. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.127 · Cited by 127
LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
Bressy, C., Lac, S., Nigri, J., Leca, J., Roques, J., Lavaut, M., Secq, V., Guillaumond, F., Bui, T.-T., Pietrasz, D., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-15-2790 · Cited by 121
Hurria, A., Browner, I. S., Cohen, H. J., Denlinger, C. S., deShazo, M., Extermann, M., Ganti, A. K., Holland, J. C., Holmes, H. M., Karlekar, M. B., et al. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0019 · Cited by 115
Meyers, F. J., Carducci, M. A., Loscalzo, M. J., Linder, J. F., Greasby, T. A., & Beckett, L. A. (2011) · Journal of Palliative Medicine · doi:10.1089/jpm.2010.0416 · Cited by 120
Smith, T. J., Dow, L. A., Virago, E., Khatcheressian, J. L., Matsuyama, R. K., & Lyckholm, L. (2011) · The Journal of Supportive Oncology · doi:10.1016/j.suponc.2010.12.005 · Cited by 110
Self-citationLopez-Acevedo, M., Havrilesky, L. J., Broadwater, G., Kamal, A. H., Abernethy, A. P., Berchuck, A., Secord, A. A., Tulsky, J. A., Valea, F. A., & Lee, P. S. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.04.010 · Cited by 111
Why do our patients get chemotherapy until the end of life?
Braga, S. A. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr416 · Cited by 104
Determinants of quality of life in patients with advanced cancer
Zimmermann, C., Burman, D., Swami, N., Krzyzanowska, M. K., Leighl, N. B., Moore, M. J., Rodin, G., & Tannock, I. F. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-010-0866-1 · Cited by 111
Zhou, G., Stoltzfus, J. C., Houldin, A. D., Parks, S. M., & Swan, B. A. (2010) · Oncology nursing forum · doi:10.1188/10.onf.e400-e410 · Cited by 99
Luta, X., Ottino, B., Hall, P. S., Bowden, J., Wee, B., Droney, J., Riley, J. L., & Marti, J. (2021) · BMC Palliative Care · doi:10.1186/s12904-021-00782-7 · Cited by 110
Current Status of Palliative Care--Clinical Implementation, Education, and Research
GRANT, M. M., Elk, R., FERRELL, B. R., Morrison, R. S., & von Gunten, C. F. (2009) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20032 · Cited by 89
Advances in Research of Adult Gliomas
Finch, A., Solomou, G., Wykes, V., Pohl, U., Bardella, C., & Watts, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020924 · Cited by 91
Drugs, cancer and end-of-life care: A case study of pharmaceuticalization?
Davis, C. (2014) · Social Science & Medicine · doi:10.1016/j.socscimed.2014.12.007 · Cited by 85
Withdrawal of anticancer therapy in advanced disease: a systematic literature review
Clarke, G., Johnston, S. J., Corrie, P. G., Kuhn, I. L., & Barclay, S. I. G. (2015) · BMC Cancer · doi:10.1186/s12885-015-1862-0 · Cited by 79
Engaging Older Adults in Health Care Decision-Making: A Realist Synthesis
Elliott, J. B., McNeil, H., Ashbourne, J., Huson, K., Boscart, V., & Stolee, P. (2016) · Patient · doi:10.1007/s40271-016-0168-x · Cited by 87
Cohen‐Gogo, S., Marioni, G., Laurent, S., Gaspar, N., Semeraro, M., Gabolde, M., Dufour, C., Valteau‐Couanet, D., & Brugières, L. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.09.008 · Cited by 76
“How Much Time Do I Have?”: Communicating Prognosis in the Era of Exceptional Responders
LeBlanc, T. W., Temel, J. S., & Helft, P. R. (2018) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_201211 · Cited by 74
Livne, R. (2014) · American Sociological Review · doi:10.1177/0003122414547756 · Cited by 74
Advance care planning conversations with palliative patients: looking through the GP’s eyes
Wichmann, A. B., van Dam, H., Thoonsen, B., Boer, T. A., Engels, Y., & Groenewoud, S. (2018) · BMC Family Practice · doi:10.1186/s12875-018-0868-5 · Cited by 73
Using a Question Prompt List As a Communication Aid in Advanced Cancer Care
Yeh, J. C., Cheng, M., Chung, C. H., & Smith, T. J. (2014) · Journal of Oncology Practice · doi:10.1200/jop.2013.001295 · Cited by 71
Self-citationChimeric antigen receptor (CAR) T cell therapy for malignant cancers: Summary and perspective
Smith, A., Oertle, J. C., III, Warren, D., & Prato, D. (2016) · Journal of Cellular Immunotherapy · doi:10.1016/j.jocit.2016.08.001 · Cited by 76
Hui, D., Con, A. H., Christie, G., & Hawley, P. H. (2009) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2009.05.017 · Cited by 68
Fletcher, S. A., Cronin, A. M., Zeidan, A. M., Odejide, O. O., Gore, S. D., Davidoff, A. J., Steensma, D. P., & Abel, G. A. (2016) · Cancer · doi:10.1002/cncr.29913 · Cited by 65
Predictors of inpatient mortality in an acute palliative care unit at a comprehensive cancer center
Elsayem, A. F., Mori, M., Parsons, H. A., Munsell, M. F., Hui, D., Delgado-Guay, M. O., Paraskevopoulos, T., Fadul, N. A., & Bruera, E. D. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-009-0631-5 · Cited by 64
Ensuring Quality Cancer Care Through the Oncology Workforce
Levit, L. A., Smith, A. P., Benz, E. J. J., & FERRELL, B. R. (2010) · Journal of Oncology Practice · doi:10.1200/jop.091067 · Cited by 63
One more chemo or one too many? Defining the limits of treatment and innovation in medical oncology
Baszanger, I. (2012) · Social Science & Medicine · doi:10.1016/j.socscimed.2012.03.023 · Cited by 62
Chemotherapy use and quality of life in cancer patients at the end of life: an integrative review
Akhlaghi, E., Lehto, R. H., Torabikhah, M., Nia, H. S., Taheri, A., Zaboli, E., & Yaghoobzadeh, A. (2020) · Health and Quality of Life Outcomes · doi:10.1186/s12955-020-01580-0 · Cited by 61
Targeted Agent Use in Cancer Patients at the End of Life
Hui, D., Karuturi, M. S., Tanco, K. C., Kwon, J. H., Kim, S., Zhang, T., Kang, J. H., Chisholm, G. B., & Bruera, E. D. (2012) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2012.07.007 · Cited by 56
Dasch, B., Kalies, H., Feddersen, B., Ruderer, C., Hiddemann, W., & Bausewein, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175124 · Cited by 56
Reville, B., Miller, M. N., Toner, R. W., & Reifsnyder, J. (2010) · Journal of Palliative Medicine · doi:10.1089/jpm.2010.0057 · Cited by 55
Keam, B., Yun, Y. H., Heo, D. S., Park, B., Cho, C., Kim, S. H., Lee, D. H., Lee, S. N., Lee, E. S., Kang, J. H., et al. (2012) · Supportive Care in Cancer · doi:10.1007/s00520-012-1689-z · Cited by 54
Randén, M., Frankling, M. H., Runesdotter, S., & Strang, P. M. (2013) · Acta Oncologica · doi:10.3109/0284186x.2012.758872 · Cited by 52
Chemotherapy at end-of-life: an integration of oncology and palliative team
Chan, W., Lam, K. O., Siu, W.-K. S., & Yuen, K.-K. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-015-3031-z · Cited by 51
Buiting, H. M., Terpstra, W. E., Dalhuisen, F., Gunnink-Boonstra, N., Sonke, G. S., & den Hartogh, G. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077959 · Cited by 51
Schildmann, J., Tan, J. O. A., Salloch, S., & Vollmann, J. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0206 · Cited by 51
Zheng, R.-J., Fu, Y., Xiang, Q.-F., Yang, M., Chen, L., Shi, Y.-K., Yu, C.-H., & Li, J.-Y. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3223-1 · Cited by 48
Using claims‐based measures to predict performance status score in patients with lung cancer
Salloum, R. G., Smith, T. J., Jensen, G. A., & Lafata, J. E. (2010) · Cancer · doi:10.1002/cncr.25677 · Cited by 48
Self-citationSeah, D. S. E., Vaz-Luís, I., Macrae, E. R., Sohl, J. J., Litsas, G., Winer, E. P., Lin, N., & Burstein, H. J. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0008 · Cited by 47
Ethical Considerations for Phase I Trials in Oncology
Bittlinger, M., Bicer, S., Peppercorn, J. M., & Kimmelman, J. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02125 · Cited by 53
Hui, D., Elsayem, A. F., Li, Z., de la Cruz, M., Palmer, J. L., & Bruera, E. D. (2010) · Cancer · doi:10.1002/cncr.24942 · Cited by 45
Palliative Chemotherapy Affects Aggressiveness of End-of-Life Care
Wu, C.-C., Hsu, T.-W., Chang, C., Lee, C., Huang, C., & Lee, C. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0445 · Cited by 45
Massa, I., Nanni, O., Foca, F., Maltoni, M. C., Derni, S., Gentili, N., Frassineti, G. L., Gardini, A. C., Valgiusti, M., Amadori, D., et al. (2018) · BMC Palliative Care · doi:10.1186/s12904-018-0339-8 · Cited by 44
SPIKE$: A Six-Step Protocol for Delivering Bad News About the Cost of Medical Care
McFarlane, J. J., Riggins, J., & Smith, T. J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.6208 · Cited by 44
Self-citationZakhour, M., LaBrant, L., Rimel, B. J., Walsh, C., Li, A. J., Karlan, B. Y., & Cass, I. A. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.06.001 · Cited by 42
Costantini, A., Baile, W. F., Lenzi, R., Costantini, M., Ziparo, V., Marchetti, P., & Grassi, L. G. (2009) · Journal of Cancer Education · doi:10.1080/08858190902876262 · Cited by 42
The Institute of Medicine Report on High-Quality Cancer Care: Implications for Oncology Nursing
FERRELL, B. R., McCabe, M. S., & Levit, L. A. (2013) · Oncology nursing forum · doi:10.1188/13.onf.603-609 · Cited by 41
Valentino, T. C. D. O., Paiva, B. S. R., de Oliveira, M. A., Hui, D., & Paiva, C. E. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-017-4031-y · Cited by 42
Dhiman, V., & Pant, D. (2021) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2020.1844751 · Cited by 41
Why are some patients in treatment for advanced cancer reluctant to consult their GP?
Åbom, B., & Pfeiffer, P. (2009) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813430802677817 · Cited by 40
Cancer immunotherapies: A hope for the uncurable?
Hamdan, F., & Cerullo, V. (2023) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2023.1140977 · Cited by 41
The Role of Palliative Care in Oncology
Agarwal, R., & Epstein, A. S. (2017) · Seminars in Interventional Radiology · doi:10.1055/s-0037-1608702 · Cited by 40
The Role of Investigational Therapy in Management of Patients With Advanced Metastatic Malignancy
Freireich, E. J., & Kurzrock, R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6543 · Cited by 38
Kim, Y. J., Hui, D., Zhang, Y., Park, J. C., Chisholm, G. B., Williams, J. L., & Bruera, E. D. (2014) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2014.10.015 · Cited by 37
Khoja, L., McGurk, A., O’Hara, C. M., Chow, S., & Hasan, J. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.11.011 · Cited by 37
The Coordination of Primary and Oncology Specialty Care at the End of Life
Han, P. K. J., & Rayson, D. (2010) · JNCI Monographs · doi:10.1093/jncimonographs/lgq003 · Cited by 36
Paradox of Prescribing Late Chemotherapy: Oncologists Explain
Bluhm, M., Connell, C. M., Vries, R. G. D., Janz, N. K., Bickel, K. E., & Silveira, M. J. (2016) · Journal of Oncology Practice · doi:10.1200/jop.2016.013995 · Cited by 36
End‐of‐life care in pediatric neuro‐oncology
Vallero, S. G., Lijoi, S., Bertin, D., Pittana, L. S., Bellini, S., Rossi, F., Peretta, P., Basso, M. E., & Fagioli, F. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25160 · Cited by 34
Determinants for Aggressive End-of-Life Care for Oral Cancer Patients
Chang, T., Su, Y., & Lee, C. (2015) · Medicine · doi:10.1097/md.0000000000000460 · Cited by 32
Palliative Care: Delivering Comprehensive Oncology Nursing Care
Dahlin, C. M. (2015) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2015.08.008 · Cited by 31
Kaufman, S. R. (2010) · Sociology of Health & Illness · doi:10.1111/j.1467-9566.2009.01200.x · Cited by 31
Potential cost savings associated with dose rounding antineoplastic monoclonal agents
Francis, S. M., Heyliger, A., Miyares, M. A., & Viera, M. (2014) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155214533369 · Cited by 29
AlFayyad, I., Al-Tannir, M. A., Al-Essa, W. A., Heena, H., & Abu-Shaheen, A. K. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213938 · Cited by 29
Beaussant, Y., Mathieu-Nicot, F., Pazart, L., Tournigand, C., Daneault, S., Cretin, É., Godard-Marceau, A., Chassagne, A., Trimaille, H., Bouleuc, C., et al. (2015) · BMC Palliative Care · doi:10.1186/s12904-015-0057-4 · Cited by 29
Valuing end-of-life care in the United States: the case of new cancer drugs
Sorenson, C. (2012) · Health Economics Policy and Law · doi:10.1017/s1744133112000217 · Cited by 28
Concrete Options and Ideas for Increasing Value in Oncology Care: The View from One Trench
Smith, T. J., & Hillner, B. E. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-s1-65 · Cited by 28
Self-citationNakano, K., Yoshida, T., Furutama, J., & Sunada, S. (2012) · Supportive Care in Cancer · doi:10.1007/s00520-011-1374-7 · Cited by 27
Mehan, S., Arora, N., Bhalla, S., Khan, A., Rehman, M. U., Alghamdi, B. S. A., Zughaibi, T. A., & Ashraf, G. M. (2022) · Molecules · doi:10.3390/molecules27113561 · Cited by 26
Chemotherapy Near the End of Life for Chinese Patients with Solid Malignancies
Jin, S., Zhang, Y.-X., He, X.-B., Fang, W., Yang, Y.-P., Lin, G., Wu, X., Li, N., Zhang, J., Zhai, L.-Z., et al. (2016) · The Oncologist · doi:10.1634/theoncologist.2016-0013 · Cited by 25
Awareness on breast cancer screening in Malaysia: a cross sectional study
Lee, M.-S., ruf, C. ‘. A. M., Izhar, D. P. N., Ishak, S. N., Jamaluddin, W. S. W., Ya’acob, S. N. M., & Kamaluddin, M. N. (2019) · Biomedicine · doi:10.1051/bmdcn/2019090318 · Cited by 25
Explaining Marginal Benefits to Patients, When “Marginal” Means Additional but Not Necessarily Small
Smith, T. J., & Hillner, B. E. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1278 · Cited by 25
Self-citationCurrent Practices in Advance Care Planning
Cohen, A. G., & Nirenberg, A. (2011) · Clinical journal of oncology nursing · doi:10.1188/11.cjon.547-553 · Cited by 26
Morin, L., Beaussant, Y., Aubry, R., Fastbom, J., & Johnell, K. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14363 · Cited by 25
Palliative Chemotherapy Near the End of Life in Oncology Patients
Zhang, Z., Chen, M., Gu, X.-L., Liu, M.-H., Zhao, W.-W., & Cheng, W.-W. (2018) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909118763338 · Cited by 25
Advance Care Planning Outcomes in African Americans: An Empirical Look at the Trust Variable
Laury, E. R., MacKenzie-Greenle, M., & Meghani, S. H. (2018) · Journal of Palliative Medicine · doi:10.1089/jpm.2018.0312 · Cited by 25
Health Care Costs in End-of-Life and Palliative Care: The Quest for Ethical Reform
Jennings, B., & Morrissey, M. B. Q. (2011) · Journal of Social Work in End-of-Life & Palliative Care · doi:10.1080/15524256.2011.623458 · Cited by 24
Cavalcanti, I. D. L., & Soares, J. C. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-68334-4_4 · Cited by 24
Nonsurgical oncological management of cancer pain
Gough, N., Miah, A. B., & Linch, M. D. (2014) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000043 · Cited by 23
Sagar, B. T. A., Yu, L., & Castel, L. D. (2017) · Journal of Medical Economics · doi:10.1080/13696998.2017.1339353 · Cited by 23
Goldberg, S. L., Paramanathan, D., Khoury, R. R., Patel, S., Jagun, D., Arunajadai, S. G., DeVincenzo, V., Benito, R. P., Gruman, B., Kaur, S., et al. (2018) · The Oncologist · doi:10.1634/theoncologist.2018-0238 · Cited by 23
Ording, A. G., Skjøth, F., Poulsen, L. Ø., Szejniuk, W. M., Jakobsen, E. H., Christensen, T. D., Noble, S., & Overvad, T. F. (2024) · JCO Oncology Practice · doi:10.1200/op-24-00526 · Cited by 22
Targeted Therapy at the End of Life in Advanced Cancer Patients
Soh, I., Yuen, Y.-C., Teo, C., Lim, S.-W., Chan, N. G. C., & Wong, A. S. C. (2012) · Journal of Palliative Medicine · doi:10.1089/jpm.2012.0050 · Cited by 22
Making Longevity in an Aging Society: Linking Ethical Sensibility and Medicare Spending
Kaufman, S. R. (2009) · Medical Anthropology · doi:10.1080/01459740903303852 · Cited by 22
Metadata
- Authors
- Harrington, S. E., & Smith, T. J.
- Affiliations
- Virginia Commonwealth University (US)
- ORCID
- Smith, Thomas J.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2008-06-11
- Volume
- 299
- Issue
- 22
- Pages
- 2667
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC3099412
- OpenAlex
- W2052621119
- Cited by
- 280
- References
- 129
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 8 · 2023: 7 · 2022: 14 · 2021: 19 · 2020: 14 · 2019: 14 · 2018: 11 · 2017: 21 · 2016: 20 · 2015: 17 · 2014: 23 · 2013: 14 · 2012: 23
- FWCI
- 22.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA116227)
- U.S. National Library of Medicine (G08LM009525)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative Care and End-of-Life Issues
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Palliative and Oncologic Care
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- end-of-life chemotherapy, palliative care, interprofessional collaboration, prognosis communication, treatment decision-making, lung cancer, hospice care, symptom management, goal setting, patient-clinician communication, chemotherapy side effects
- MeSH terms
- Antineoplastic Agents, Attitude to Death, Decision Making, Hospices, Humans, Interprofessional Relations, Lung Neoplasms, Male, Medical Oncology, Middle Aged, Palliative Care, Patient Acceptance of Health Care, Physician-Patient Relations, Prognosis, Terminally Ill
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review